d'Hepatogastroenterologie, Centre Hospitalier General d'Evreux, France SUMMARY We report the cases of one patient with the acquired immunodeficiency syndrome as a result of human immunodeficiency virus type 1/lymphadenopathy associated virus type 1/human T-cell lymphotrophic virus type III (HIV-1/LAV-1/HTLV-III) infection and of another patient with AIDS related complex caused by human immunodeficiency virus type 2/lymphadenopathy associated virus type 2 (HIV-2/LAV-2) infection, who were suffering from cholangitis. The manifestations and possible mechanisms for cholangitis in these patients and in 10 previously reported similar cases are reviewed.
Case reports PATIENT 1 On 10 October 1986, a 47 year old woman was admitted to Hopital Beaujon for liver and biliary tract evaluation. The patient was born in France and had remained there all her life. There was no history of intravenous drug abuse. Past history was remarkable: (a) several operations, requiring transfusions of blood products, for ovarian cysts and uterine fibroma in 1977, 1980, 1982 and 1983; (b) (Fig. 1) ; there was diffuse beadings of the intrahepatic bile ducts (Fig. 1) stricturing. Examination and cultures of a sample of bile and of a specimen of mucosa obtained through endoscopic cannulation of the bile duct showed no bacteria, mycobacteria, fungi, or parasites. Specimens of bile duct mucosa were obtained using endoscopic forceps introduced through the duodenal papilla. Histological examination of these specimens ( Fig. 3) showed minute erosions of the mucosal lining covered with fibrin and polymorphonuclear exudates. The most striking lesions were seen in the submucosa. There was marked oedema and inflammatory infiltrates consisting of round and polymorphonuclear cells. There was no abscess, granuloma, or intranuclear inclusion suggesting cytomegalovirus infection. Stains for bacteria, fungi and mycobacteria were all negative. Examination of a hepatic specimen obtained by percutaneous needle biopsy (Fig. 4 with ELISA, Western Blot and RIPA failed to show antibodies to HIV-1/LAV-1/HTLV-Ill. Infection with a recently identified viral agent, HIV-2/LAV-2, was shown by detection of antibodies to HIV-2/ LAV-2 in the patient's serum and by isolation of the virus on the peripheral blood lymphocytes. As in the majority of HIV-1/LAV-1/HTLV-III infections in Africa, the risk factors recognised in Europe and North America were absent in our patient. He was not a homosexual or a drug addict. Moreover, he had been living in Senegal, an area where HIV-i/LAV-l/ HTLV-III infection is not endemic. In contrast, LAV-2 was originally identified in AIDS patients from Guinea-Bissau,3 which is the native country of our patient's parents and one which he visited repeatedly.
A remarkable association to AIDS or ARC in our patients was cholangitis. A few similar cases of cholangitis affecting AIDS patients have been recently reported,"'S the main characteristics of which are presented in Table 1 . The features of cholangitis associated to ARC or AIDS can be summarised as follows: (a) in the majority of the cases, manifestations of acute symptomatic acalculous cholecystitis led to the recognition of the asymptomatic cholangitis; (b) the most common abnormality of liver tests was a marked increase in serum alkaline phosphatase; (c) involvement of intrahepatic bile ducts was indistinguishable from that seen in primary sclerosing cholangitis; (d) involvement of the common bile duct was distinct from that seen in primary sclerosing cholangitis and consisted of dilatation with or without stenosis and markedly irregular margins of the duct; (e) liver histology was non-diagnostic; (f) microscopic examination of the wall of the bile ducts and gall bladder usually showed superficial ulcerations, covered with purulent exudates, and subepithelial oedema.
The prevalence of cholangitis in AIDS or ARC patients, although admittedly low, may well be currently underestimated because the condition is usually asymptomatic or associated with non-specific changes in liver tests and liver histology. In a series of nine unselected patients with AIDS, necropsy showed unexplained dilatation of the common bile duct in two of three patients with high alkaline phosphatases.'' Cholangitis must therefore be added to the list of the multiple conditions associated with abnormal liver tests in AIDS patients."'"
The cause of cholangitis in our patients as in previously reported cases is uncertain. Various infectious agents were identified in bile or in the wall of the gall bladder or bile ducts, and, therefore, might be implicated. As shown in Table 2 , cytomegalovirus and Cryptosporidium were the most commonly reported species. Candida albicans was also reported in few instances of cholangitis'4 and cholecystitis4s affecting patients with AIDS'4 '5 or other forms of immunodeficiency. Cryptococcus neoformans cholangitis has been described in patients without AIDS."' Surprisingly, Cryptococcus neoformans has not been reported hitherto in association with cholangitis in AIDS patients in whom this agent causes a variety of opportunistic infections. In patient 2, none of the above mentioned infectious agents could be identified in bile or in a specimen of bile duct mucosa. Therefore, the role of Salmonella typhimurium which was isolated from blood in several occasions in this patient may be envisaged to account for cholangitis. As there are similarities between primary sclerosing cholangitis and AIDS related cholangitis, both conditions might share common aetiological factors. This view is reinforced by several reports of 'primary' sclerosing cholangitis affecting patients with various forms of underlying immunodeficiency."" Indeed, several abnormalities of the immune system have been identified in patients with primary sclerosing cholangitis. Differences between primary sclerosing cholangitis and AIDS are obvious. In particular, in patients with primary sclerosing cholangitis, the inflammatory cell infiltrates surrounding diseased bile ducts have been found to be rich in T4 lymphocytes, the subpopulation specifically depleted in AIDS 
